Multiple Sclerosis and Kaposi's Sarcoma?Chronic Diseases Associated with New Human Herpesviruses?

References

• Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med 1990; 323: 1573–80.
   Google Scholar
• Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 1992; 327: 293–301.
   PubMed Web of Science ®Google Scholar
• Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993; 259: 946–51.
   PubMed Web of Science ®Google Scholar
• Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999; 12: 295–302.
   Google Scholar
• Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995; 47: 425–48.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 6: 382–427.
   PubMed Web of Science ®Google Scholar
• Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M. Twin study of multiple sclerosis: an epidemiologic inquiry. Neurology 1978; 28: 978–87.
   Google Scholar
• Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986; 315: 1638–42.
   PubMed Web of Science ®Google Scholar
• Kinnunen E, Juntunen J, Ketonen L, Koskimies S, Konttinen YT, Salmi T, et al. Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch Neurol 1988; 45: 1108–11.
   PubMedGoogle Scholar
• Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347: 1728–30.
   PubMed Web of Science ®Google Scholar
• Granieri E, Casetta I. Common childhood and adolescent infections and multiple sclerosis. Neurology 1997; 49: S42–54.
   PubMed Web of Science ®Google Scholar
• Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993; 240: 417–22.
   Google Scholar
• Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985; 1: 1313–5.
   Google Scholar
• Olsson T, Zhi WW, Hojeberg B, Kostulas V, Jiang YP, Anderson G, et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest 1990; 86: 981–5.
   PubMed Web of Science ®Google Scholar
• Link H, Sun JB, Wang Z, Xu Z, Love A, Fredrikson S, et al. Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992; 38: 63–73.
   PubMed Web of Science ®Google Scholar
• Sun J, Link H, Olsson T, Xiao BG, Andersson G, Ekre HP, et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 1991; 146: 1490–5.
   PubMed Web of Science ®Google Scholar
• Sun JB, Olsson T, Wang WZ, Xiao BG, Kostulas V, Fredrikson S, et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991; 21: 1461–8.
   PubMed Web of Science ®Google Scholar
• Dahl H, Linde A, Sundqvist VA, Wahren B. An enzyme-linked immunosorbent assay for IgG antibodies to human herpes virus 6. J Virol Methods 1990; 29: 313–23.
   PubMed Web of Science ®Google Scholar
• Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331: 432–8.
   Google Scholar
• Mukai T, Yamamoto T, Kondo T, Kondo K, Okuno T, Kosuge H, et al. Molecular epidemiological studies of human herpesvirus 6 in families. J Med Virol 1994; 42: 224–7.
   PubMed Web of Science ®Google Scholar
• Asada H, Klaus-Kovtun V, Golding H, Katz SI, Blauvelt A. Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol 1999; 73: 4019–28.
   PubMed Web of Science ®Google Scholar
• He J, McCarthy M, Zhou Y, Chandran B, Wood C. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996; 70: 1296–300.
   Google Scholar
• Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991; 72: 1401–8.
   Google Scholar
• Saito Y, Sharer LR, Dewhurst S, Blumberg BM, Hall CB, Epstein LG. Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol 1995; 1: 30–9.
   PubMed Web of Science ®Google Scholar
• Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99: 817–27.
   PubMed Web of Science ®Google Scholar
• Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065–7.
   PubMed Web of Science ®Google Scholar
• Hidaka Y, Kusuhara K, Takabayashi A, Okada K, Miyazaki C, Aoki T, et al. Symptomatic primary infection with human herpesvirus 6 variant A. Clin Infect Dis 1997; 24: 1022–3.
   PubMed Web of Science ®Google Scholar
• Caserta MT, Hall CB, Schnabel K, McIntyre K, Long C, Costanzo M, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170: 1586–9.
   PubMed Web of Science ®Google Scholar
• Yamanishi K, Kondo K, Mukai T, Kondo T, Nagafuji H, Kato T, et al. Human herpesvirus 6 (HHV-6) infection in the central nervous system. Acta Paediatr Jpn 1992; 34: 337–43.
   PubMedGoogle Scholar
• Asano Y, Yoshikawa T, Kajita Y, Ogura R, Suga S, Yazaki T, et al. Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992; 67: 1484–5.
   PubMed Web of Science ®Google Scholar
• Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356–13560.
   PubMed Web of Science ®Google Scholar
• Huang LM, Lee CY, Lee PI, Chen JM, Wang PJ. Meningitis caused by human herpesvirus-6. Arch Dis Child 1991; 66: 1443–4.
   PubMed Web of Science ®Google Scholar
• Ishiguro N, Yamada S, Takahashi T, Takahashi Y, Togashi T, Okuno T, et al. Meningo-encephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 1990; 79: 987–9.
   PubMed Web of Science ®Google Scholar
• Knox KK, Harrington DP, Carrigan DR. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 1995; 45: 288–92.
   Google Scholar
• Sloots TP, Mackay IM, Carroll P. Meningoencephalitis in an adult with human herpesvirus-6 infection. Med J Aust 1993; 159: 838.
   Google Scholar
• Yanagihara K, Tanaka-Taya K, Itagaki Y, Toribe Y, Arita K, Yamanishi K, et al. Human herpesvirus 6 meningoencephalitis with sequelae. Pediatr Infect Dis J 1995; 14: 240–2.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Nakashima T, Suga S, Asano Y, Yazaki T, Kimura H, et al. Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. Pediatrics 1992; 89: 888–90.
   PubMed Web of Science ®Google Scholar
• Hall CB, Caserta MT, Schnabel KC, Long C, Epstein LG, Insel RA, et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998; 26: 132–7.
   PubMed Web of Science ®Google Scholar
• Carrigan DR, Harrington D, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology 1996; 47: 145–8.
   Google Scholar
• Novoa LJ, Nagra RM, Nakawatase T, Edwards-Lee T, Tourtellotte WW, Cornford ME. Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. J Med Virol 1997; 52: 301–8.
   Google Scholar
• Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 7440–4.
   PubMed Web of Science ®Google Scholar
• Ablashi DV, Lapps W, Kaplan M, Whitman JE, Richert JR, Pearson GR. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult Scler 1998; 4: 490–6.
   PubMed Web of Science ®Google Scholar
• Sola P, Merelli E, Marasca R, Poggi M, Luppi M, Montorsi M, et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatr 1993; 56: 917–9.
   PubMed Web of Science ®Google Scholar
• Wilborn F, Schmidt CA, Brinkmann V, Jendroska K, Oettle H, Siegert W. A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994; 49: 213–4.
   PubMed Web of Science ®Google Scholar
• Friedman JE, Lyons MJ, Cu G, Ablashl DV, Whitman JE, Edgar M, et al. The association of the human herpesvirus-6 and MS. Mult Scler 1999; 5: 355–62.
   PubMed Web of Science ®Google Scholar
• Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997; 3: 1394–7.
   PubMed Web of Science ®Google Scholar
• Liedtke W, Malessa R, Faustmann PM, Eis-Hubinger AM. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995; 1: 253–8.
   Google Scholar
• Nielsen L, Larsen AM, Munk M, Vestergaard BF. Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand Suppl 1997; 169: 76–8.
   PubMedGoogle Scholar
• Enbom M, Martin C, Fredrikson S, Jägdahl L, Dahl H, Linde A. Intrathecal antibody production to lymphotropic herpesviruses in patients with multiple sclerosis. Neurol Infect Epidemiol 1997; 2: 107–11.
   Google Scholar
• Merelli E, Bedin R, Sola P, Barozzi P, Mancardi GL, Ficarra G, et al. Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children. J Neurol 1997; 244: 450–4.
   PubMed Web of Science ®Google Scholar
• Mirandola P, Stefan A, Brambilla E, Campadelli-Fiume G, Grimaldi LME. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 1999; 53: 1367–8.
   Google Scholar
• Martin C, Enbom M, Soderstrom M, Fredrikson S, Dahl H, Lycke J, et al. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997; 95: 280–3.
   PubMed Web of Science ®Google Scholar
• Mayne M, Krishnan J, Metz L, Nath A, Auty A, Sahai BM, et al. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann Neurol 1998; 44: 391–4.
   PubMed Web of Science ®Google Scholar
• Rotola A, Cassai E, Tola MR, Granieri E, Di Luca D. Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatr 1999; 67: 529–31.
   Google Scholar
• Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J AIDS Hum Retrovirol 1995; 9: 69–73.
   PubMedGoogle Scholar
• Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, et al. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 2000; 182: 1321–5.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee K, Park J, Kim M, Shin W. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. Eur Neurol 2000; 43: 170–3.
   Google Scholar
• Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000; 47: 306–13.
   Google Scholar
• Enbom M, Wang FZ, Fredrikson S, Martin C, Dahl H, Linde A. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 1999; 6: 545–9.
   PubMedGoogle Scholar
• Lycke J, Svennerholm B, Hjelmquist E, Frisen L, Badr G, Andersson M, et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Neurol 1996; 243: 214–24.
   Google Scholar
• Kaposi M. Idiopathisches multiples pigment sarcoma der Haut. Arch Dermatol Syphil 1872; 4: 265.
   Google Scholar
• Adams V, Kempf W, Hassam S, Briner J, Schmid M, Moos R, et al. Detection of several types of human papilloma viruses in AIDS-associated Kaposi’s sarcoma. J Med Virol 1995; 46: 189–93.
   PubMed Web of Science ®Google Scholar
• Kempf W, Adams V, Hassam S, Schmid M, Moos R, Briner J, et al. Detection of human herpesvirus type 6, human herpesvirus type 7, cytomegalovirus and human papillomavirus in cutaneous AIDS-associated Kaposi’s sarcoma. Verh Dtsch Ges Pathol 1994; 78: 260–4.
   PubMedGoogle Scholar
• Monini P, Rotola A, de Lellis L, Corallini A, Secchiero P, Albini A, et al. Latent BK virus infection and Kaposi’s sarcoma pathogenesis. Int J Cancer 1996; 66: 717–22.
   PubMed Web of Science ®Google Scholar
• Siegal B, Levinton-Kriss S, Schiffer A, Sayar J, Engelberg I, Vonsover A, et al. Kaposi’s sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer 1990; 65: 492–8.
   Google Scholar
• Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266: 1865–9.
   PubMed Web of Science ®Google Scholar
• Boshoff C, Whitby D, Hatziioannou T, Fisher C, v d Walt J, Hatzakis A, et al. Kaposi’s sarcoma associated herpesvirus in HIV-negative Kaposi’s sarcoma. Lancet 1995; 345: 1043–4.
   Google Scholar
• Dupin N, Grandadam M, Calvez V, Gorin I, Aubin JT, Havard S, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi’s sarcoma. Lancet 1995; 345: 761–3.
   PubMed Web of Science ®Google Scholar
• Huang YQ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi’s sarcoma. Lancet 1995; 345: 759–61.
   PubMed Web of Science ®Google Scholar
• Moore P, Chang Y. Detection of herpesvirus-like DNA sequences in patients with and those without HIV infection. N Engl J Med 1995; 332: 1181–815.
   PubMed Web of Science ®Google Scholar
• Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997; 71: 5915–21.
   PubMed Web of Science ®Google Scholar
• Friborg J Jr, Kong W, Hottiger MO, Nabel GJ. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999; 402: 889–94.
   PubMed Web of Science ®Google Scholar
• Schwam DR, Luciano RL, Mahajan SS, Wong L, Wilson AC, FriborgJr J, et al. Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies p53 inhibition by the LANA protein of KSHV protects against cell death. J Virol 2000; 74: 8532–40.
   PubMed Web of Science ®Google Scholar
• Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 1998; 243: 208–17.
   PubMed Web of Science ®Google Scholar
• Raab MS, Albrecht JC, Birkmann A, Yaguboglu S, Lang D, Fleckenstein B, et al. The immunogenic glycoprotein gp35–37 of human herpesvirus 8 is encoded by open reading frame K81. J Virol 1998; 72: 6725–31.
   PubMed Web of Science ®Google Scholar
• Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, et al. Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133–8.
   PubMed Web of Science ®Google Scholar
• Poole LJ, Zong JC, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, et al. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi’s sarcoma-associated herpesvirus. Reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 1999; 73: 6646–60.
   Google Scholar
• Zong JC, Ciufo DM, Alcendor DJ, Wan XY, Nicholas J, Browning PJ, et al. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi’s sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 1999; 73: 4156–70.
   PubMed Web of Science ®Google Scholar
• Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 2000; 181: 1562–8.
   Google Scholar
• Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, et al. Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995; 1: 1274–8.
   PubMed Web of Science ®Google Scholar
• Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, et al. Monocytes in Kaposi’s sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997; 71: 7963–8.
   PubMed Web of Science ®Google Scholar
• Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, et al. Human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996; 183: 2385–90.
   PubMed Web of Science ®Google Scholar
• Renne R, Blackbourn D, Whitby D, Levy J, Ganem D. Limited transmission of Kaposi’s sarcoma-associated herpesvirus in cultured cells. J Virol 1998; 72: 5182–788.
   Google Scholar
• Kedes DH, Ganem D. Sensitivity of Kaposi’s sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 1997; 99: 2082–6.
   PubMed Web of Science ®Google Scholar
• Medveczky MM, Horvath E, Lund T, Medveczky PG. In vitro antiviral drug sensitivity of the Kaposi’s sarcoma-associated herpesvirus. AIDS 1997; 11: 1327–32.
   PubMed Web of Science ®Google Scholar
• Zoeteweij JP, Eyes ST, Orenstein JM, Kawamura T, Wu LJ, Chandran B, et al. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: Characterization of antiherpesvirus agents. J Virol 1999; 73: 5894–902.
   PubMed Web of Science ®Google Scholar
• Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW. AIDS-associated Kaposi’s sarcoma. Science 1995; 267: 1078–9.
   Google Scholar
• Benfield TL, Kirk O, Elbrond B, Pedersen C. Complete histological regression of Kaposi’s sarcoma following treatment with protease inhibitors despite persistence of HHV-8 in lesions. Scand J Infect Dis 1998; 30: 613–5.
   PubMed Web of Science ®Google Scholar
• Cattelan AM, Calabro ML, Aversa SML, Zanchetta M, Meneghetti F, De Rossi A, et al. Regression of AIDS-related Kaposi’s sarcoma following antiretroviral therapy with protease inhibitors: Biological correlates of clinical outcome. Eur J Cancer 1999; 35: 1809–15.
   Google Scholar
• Lebbe C, Blum L, Pellet C, Blanchard G, Verola O, Morel P, et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi’s sarcoma. AIDS 1998; 12: F45–9.
   PubMed Web of Science ®Google Scholar
• Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 1999; 81: 893–7.
   PubMed Web of Science ®Google Scholar
• Chatlynne LG, Lapps W, Handy M, Huang YO, Masood R, Hamilton AS, et al. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients and Kaposi’s sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998; 92: 53–8.
   PubMed Web of Science ®Google Scholar
• Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, et al. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden—variable frequencies found in a multicenter serological study. J Med Virol 2000; 62: 498–504.
   PubMed Web of Science ®Google Scholar
• Gao S, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 1996; 2: 925–8.
   PubMed Web of Science ®Google Scholar
• Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918–24.
   PubMed Web of Science ®Google Scholar
• Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet 1996; 348: 858–61.
   Google Scholar
• Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, et al. Interassay correlation of human herpesvirus 8 serologic tests. J Infect Dis 1998; 178: 304–9.
   PubMed Web of Science ®Google Scholar
• Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, et al. Risk factors for Kaposi’s-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981–1996. Int J Cancer 1998; 77: 543–8.
   PubMed Web of Science ®Google Scholar
• Smith NA, Sabin CA, Gopal R, Bourboulia D, Labbet W, Boshoff C, et al. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 1999; 180: 600–6.
   PubMed Web of Science ®Google Scholar
• Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi’s sarcoma patients. Science 1995; 268: 582–3.
   PubMed Web of Science ®Google Scholar
• Corbellino M, Bestetti G, Galli M, Parravicini C. Absence of HHV-8 in prostate and semen. N Engl J Med 1996; 335: 1237.
   PubMed Web of Science ®Google Scholar
• Diamond C, Huang ML, Kedes DH, Speck C, RankinJr GW, Ganem D, et al. Absence of detectable human herpesvirus 8 in the semen of human immunodeficiency virus-infected men without Kaposi’s sarcoma. J Infect Dis 1997; 176: 775–7.
   PubMed Web of Science ®Google Scholar
• Gupta P, Singh MK, Rinaldo C, Ding M, Farzadegan H, Saah A, et al. Detection of Kaposi’s sarcoma herpesvirus DNA in semen of homosexual men with Kaposi’s sarcoma. AIDS 1996; 10: 1596–8.
   PubMed Web of Science ®Google Scholar
• Howard MR, Whitby D, Bahadur G, Suggett F, Boshoff C, Tenant-Flowers M, et al. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS 1997; 11: F15–9.
   Google Scholar
• Huang YQ, Li JJ, Poiesz BJ, Kaplan MH, Friedman-Kien AE. Detection of the herpesvirus-like DNA sequences in matched specimens of semen and blood from patients with AIDS-related Kaposi’s sarcoma by polymerase chain reaction in situ hybridization. Am J Pathol 1997; 150: 147–53.
   Google Scholar
• Lin J, Lin S, Mar E, Pellett P, Stamey F, Stewart J, et al. Is Kaposi’s sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet 1995; 346: 1601–2.
   PubMed Web of Science ®Google Scholar
• Marchioli CC, Love JL, Abbott LZ, Huang YQ, Remick SC, Surtento-Reodica N, et al. Prevalence of human herpesvirus 8 DNA sequences in several patient populations. J Clin Microbiol 1996; 34: 2635–8.
   Google Scholar
• Monini P, Lellis LD, Fabris M, Rigolin F, Cassai E. Kaposi’s sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996; 334: 1168–72.
   Google Scholar
• Monini P, Howard MR, Rimessi P, de Lellis L, Schulz TF, Cassai E. Human herpesvirus DNA in prostate and semen from HIV-negative individuals in Italy. AIDS 1997; 11: 1530–2.
   Google Scholar
• Viviano E, Vitale F, Ajello F, Perna AM, Villafrate MR, Bonura F, et al. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily. AIDS 1997; 11: 607–12.
   PubMed Web of Science ®Google Scholar
• Lin JC, Lin SC, Mar EC, Pellett PE, Stamey FR, Stewart JA, et al. Is Kaposi’s-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? [Retracted by Lin JC, Lin SC, Mar EC, Pellett PE, Stamey FR, Stewart JA, et al. In: Lancet 1998; 351: 1365]. Lancet 1995; 346: 1601–2.
   Google Scholar
• Enbom M, Strand A, Falk K, Linde A. Detection of HHV-8, but not EBV, DNA in cervical secretions from Swedish women by real-time PCR. Sex Transm Dis 2001. In press.
   Google Scholar
• Calabro ML, Fiore JR, Favero A, Lepera A, Saracino A, Angarano G, et al. Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1999; 179: 1534–7.
   PubMed Web of Science ®Google Scholar
• Chan PK, Li WH, Chan MY, Cheng AF. Detection of human herpesvirus 8 in cervical cells of Chinese women with abnormal papanicolaou smears. Clin Infect Dis 1999; 29: 1584–5.
   PubMed Web of Science ®Google Scholar
• Whitby D, Smith NA, Matthews S, O’Shea S, Sabin CA, Kulasegaram R, et al. Human herpesvirus 8: Seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis 1999; 179: 234–6.
   Google Scholar
• Andreoni M, El-Sawaf G, Rezza G, Ensoli B, Nicastri E, Ventura L, et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of nonsexual transmission. J Natl Cancer Inst 1999; 91: 465–9.
   PubMedGoogle Scholar
• Gessain A, Mauclere P, van Beveren M, Plancoulaine S, Ayouba A, Essame-Oyono JL, et al. The human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999; 81: 189–92.
   Google Scholar
• Mayama S, Cuevas L, Sheldon J, Omar O, Smith D, Okong P, et al. Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77: 817–20.
   PubMed Web of Science ®Google Scholar
• Karakis I, Davidovici B, Sarov B, Bourboulia D, Benharroch D, Ariad S, et al. Intra-familial transmission of HHV-8 in Israel. European Virology 2000, Glasgow, UK, 2000 [Abstract].
   Google Scholar
• Blackbourn DJ, Lennette ET, Ambroziak J, Mourich DV, Levy JA. Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis 1998; 177: 213–6.
   Google Scholar
• Koelle DM, Huang ML, Chandran B, Vieira J, Piepkorn M, Corey L. Frequent detection of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997; 176: 94–102.
   PubMed Web of Science ®Google Scholar
• Lucht E, Brytting M, Bjerregaard L, Julander I, Linde A. Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls. Clin Infect Dis 1998; 27: 137–41.
   Google Scholar
• Gao S, Kingsley L, Hoover D, Spira T, Rinaldo C, Saah A, et al. Seroconversion to antibodies against Kaposi’s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi’s sarcoma. N Engl J Med 1996; 335: 233–41.
   PubMed Web of Science ®Google Scholar
• Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 1995; 346: 799–802.
   Google Scholar
• Judde JG, Lacoste V, Briere J, Kassa-Kelembho E, Clyti E, Couppie P, et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi’s sarcoma and other diseases. J Natl Cancer Inst 2000; 92: 729–36.
   Google Scholar
• Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, et al. AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243: 223–6.
   PubMed Web of Science ®Google Scholar
• Miles SA, Martinez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, et al. Oncostatin M as a potent mitogen for AIDS-Kaposi’s sarcoma-derived cells. Science 1992; 255: 1432–4.
   PubMed Web of Science ®Google Scholar
• Nair BC, DeVico AL, Nakamura S, Copeland TD, Chen Y, Patel A, et al. Identification of a major growth factor for AIDS-Kaposi’s sarcoma cells as oncostatin M. Science 1992; 255: 1430–2.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Salahuddin SZ, Biberfeld P, Ensoli B, Markham PD, Wong-Staal F, et al. Kaposi’s sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4 + T cells. Science 1988; 242: 426–30.
   Google Scholar
• Monini P, Colombini S, Sturzl M, Goletti D, Cafaro A, Sgadari C, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi’s sarcoma. Blood 1999; 93: 4044–58.
   PubMed Web of Science ®Google Scholar
• Carbone A, Gaidano G. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 1997; 97: 515–22.
   PubMed Web of Science ®Google Scholar
• Cesarman E, Chang Y, Moore PS, Said J, Knowles D. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186–91.
   Google Scholar
• Peterson BA, Frizzera G. Multicentric Castleman’s disease. Semin Oncol 1993; 20: 636–47.
   PubMed Web of Science ®Google Scholar
• Cesarman E, Knowles DM. The role of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin Cancer Biol 1999; 9: 165–74.
   PubMed Web of Science ®Google Scholar
• Burger R, Wendler J, Antoni K, Helm G, Kalden JR, Gramatzki M. Interleukin-6 production in B-cell neoplasias and Castleman’s disease: evidence for an additional paracrine loop. Ann Hematol 1994; 69: 25–31.
   PubMed Web of Science ®Google Scholar
• Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood 1989; 74: 1360–7.
   PubMed Web of Science ®Google Scholar
• Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739–44.
   PubMed Web of Science ®Google Scholar
• Parravinci C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman’s disease. Am J Pathol 1997; 151: 1517–22.
   Google Scholar
• Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, et al. Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997; 276: 1851–4.
   PubMed Web of Science ®Google Scholar
• Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, Ma HJ, et al. Localization of Kaposi’s sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1997; 90: 4278–82.
   PubMed Web of Science ®Google Scholar
• Tarte K, Chang Y, Klein B. Kaposi’s sarcoma-associated herpesvirus and multiple myeloma: lack of criteria for causality. Blood 1999; 93: 3159–63.
   Google Scholar
• IARC. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17–24 June 1997. IARC Monogr Eval Carcinog Risks Hum 1997; 70: 1–492.
   Google Scholar
• Margulis M, Soloviev V, Schubldze A. Aetiology and pathogenesis of acute sporadic disseminated encephalomyelitis and multiple sclerosis. J Neurol Neurosurg Psychiatry 1946; 9: 62–74.
   Google Scholar
• Adams J, Imagawa D. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 1962; 111: 562–6.
   PubMed Web of Science ®Google Scholar
• Gudnadottir M, Helgadottir H, Bjarnason O, Jonsdottir K. Virus isolated from the brain of a patient with multiple sclerosis. Exp Neurol 1964; 9: 85–95.
   PubMed Web of Science ®Google Scholar
• Bergstrom T, Andersen O, Vahlne A. Isolation of herpes simplex virus type 1 during first attack of multiple sclerosis. Ann Neurol 1989; 26: 283–5.
   Google Scholar
• Palsson P, Pattison I, Field E. Transmission experiments with multiple sclerosis. In: Gajdusek C, Gibbs C, Alpers M, eds. Slow, latent and temperate virus infections. Washington D. C.: US Government Printing Office, 1965: 49–54.
   Google Scholar
• Carp RI, Licursi PC, Merz PA, Merz GS. Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients. J Exp Med 1972; 136: 618–29.
   PubMed Web of Science ®Google Scholar
• Meulen VT, Koprowski H, Iwasaki Y, Kackell YM, Muller D. Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus. Lancet 1972; 2: 1–5.
   Google Scholar
• Mitchell DN, Porterfield JS, Micheletti R, Lange LS, Goswami KK, Taylor P, et al. Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis. Lancet 1978; 2: 387–91.
   PubMed Web of Science ®Google Scholar
• Wroblewska Z, Gilden D, Devlin M, Huang ES, Rorke LB, Hamada T, et al. Cytomegalovirusisolation from a chimpanzee with acute demyelinating disease after inoculation of multiple sclerosis brain cells. Infect Immun 1979; 25: 1008–15.
   PubMed Web of Science ®Google Scholar
• Melnick JL, Seidel E, Inoue YK, Nishibe Y. Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis. Lancet 1982; 1: 830–3.
   PubMed Web of Science ®Google Scholar
• Vagabov RM, Skvortsova TM, Gofman P Yu, Barinsky IF. Isolation of the tick-borne encephalitis virus from a patient with multiple sclerosis. Acta Virol 1982; 26: 403.
   PubMed Web of Science ®Google Scholar
• Koprowski H, DeFreitas EC, Harper ME, Sandberg-Wollheim M, Sheremata WA, Robert-Guroff M, et al. Multiple sclerosis andhumanT-celllymphotropicretroviruses. Nature 1985; 318: 154–60.
   Google Scholar
• Goswami KK, Randall RE, Lange LS, Russell WC. Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients. Nature 1987; 327: 244–7.
   PubMed Web of Science ®Google Scholar
• Perron H, Geny C, Laurent A, Mouriquand C, Pellat J, Perret J, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989; 140: 551–61.
   PubMedGoogle Scholar
• Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 1997; 94: 7583–8.
   Google Scholar
• Hodge MJ, Wolfson C. Canine distemper virus and multiple sclerosis. Neurology 1997; 49: S62–9.
   PubMed Web of Science ®Google Scholar
• Munch M, Hvas J, Christensen T, Moller-Larsen A, Haahr S. The implications of Epstein-Barr virus in multiple sclerosis—a review. Acta Neurol Scand Suppl 1997; 169: 59–64.
   PubMedGoogle Scholar
• Ross RT. The varicella-zoster virus and multiple sclerosis. J Clin Epidemiol 1998; 51: 533–5.
   PubMed Web of Science ®Google Scholar
• Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD, et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46: 6–14.
   PubMed Web of Science ®Google Scholar
• Nicholas J, Ruvolo V, Zong J, Ciufo D, Guo HG, Reitz MS, et al. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J Virol 1997; 71: 1963–74.
   PubMed Web of Science ®Google Scholar
• Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997; 390: 184–7.
   PubMed Web of Science ®Google Scholar
• Li M, Lee H, Yoon DW, Albrecht JC, Fleckenstein B, Neipel F, et al. Kaposi’s sarcoma-associated herpesvirus encodes a functional cyclin. J Virol 1997; 71: 1984–91.
   PubMed Web of Science ®Google Scholar
• Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, et al. The cyclin encoded by Kaposi’s sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 1997; 71: 4193–8.
   Google Scholar
• Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden K, et al. Cyclin encoded by KS herpesvirus. Nature 1996; 382: 410.
   PubMed Web of Science ®Google Scholar
• Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997; 385: 347–50.
   PubMed Web of Science ®Google Scholar
• Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, et al. Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. J Virol 1996; 70: 8218–23.
   PubMed Web of Science ®Google Scholar
• Guo HG, Browning P, Nicholas J, Hayward GS, Tschachler E, Jiang YW, et al. Characterization of a chemokine receptor related gene in human herpesvirus 8 and its expression in Kaposi’s sarcoma. Virology 1997; 228: 371–8.
   PubMed Web of Science ®Google Scholar
• Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, et al. G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angio-genesis activator. Nature 1998; 391: 86–9.
   PubMed Web of Science ®Google Scholar
• Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Kaposi’s sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 1997; 3: 293–8.
   Google Scholar
• Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS, et al. Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 1997; 94: 690–4.
   PubMed Web of Science ®Google Scholar
• Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci USA 1997; 94: 1172–6.
   PubMed Web of Science ®Google Scholar
• Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517–21.
   PubMed Web of Science ®Google Scholar
• Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi’s sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 1997; 272: 19625–31.
   Google Scholar
• Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, et al. Kaposi’s sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 1997; 3: 287–92.
   PubMed Web of Science ®Google Scholar
• Neipel F, Albrecht JC, Ensser A, Huang YQ, Li JJ, FriedmanKien AE, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997; 71: 839–42.
   PubMed Web of Science ®Google Scholar
• Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, et al. A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus. Science 1997; 277: 1656–9.
   PubMed Web of Science ®Google Scholar
• Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves J, Schweickart VL, et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997; 278: 290–4.
   PubMed Web of Science ®Google Scholar
• Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 14862–7.
   PubMed Web of Science ®Google Scholar
• Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997; 15: 1979–85.
   PubMed Web of Science ®Google Scholar